CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- 4 Grant or award Chief Operating Officer acquired 45,800 shares (grant or award)
- 4 Grant or award President acquired 45,800 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 105,700 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 2,453 shares at an average $30.75 ($75,430)
- 4 Open-market sale General Counsel sold 2,523 shares at an average $30.75 ($77,582)
- 4 Open-market sale Chief Operating Officer sold 16,482 shares at an average $30.75 ($506,822)
- 4 Open-market sale President sold 4,436 shares at an average $30.75 ($136,407)
- 4 Open-market sale Chief Executive Officer sold 13,043 shares at an average $30.75 ($401,073)
- 4 Open-market sale Chief Operating Officer sold 12,677 shares at $26.28 ($333,152)
- 4 Grant or award Chief Medical Officer acquired 42,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 2,922 shares at an average $21.45 ($62,673)
- 4 Open-market sale Chief Executive Officer sold 8,854 shares at an average $21.45 ($189,908)
- 4 Open-market sale Chief Operating Officer sold 12,695 shares at an average $21.45 ($272,293)
- 4 Open-market sale President sold 4,870 shares at an average $21.45 ($104,456)
- 4 Grant or award Director acquired 4,100 shares (grant or award)
- 4 Grant or award Director acquired 4,100 shares (grant or award)
- 4 Grant or award Director acquired 4,100 shares (grant or award)
- 4 Grant or award Director acquired 4,100 shares (grant or award)
- 4 Grant or award Director acquired 4,100 shares (grant or award)
Page 8 of 15 · 290 filings